Skip to main content

Advertisement

SpringerLink
Log in

Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We have carried out tests for antibody-dependent cell-mediated cytotoxicity (ADCC) against extra ocular muscle (EOM), Müller’s muscle, orbital fibroblasts and skeletal muscle in patients with thyroid-associated ophthalmopathy (TAO) and related eye disorders. Cytotoxicity was measured as lactate dehydrogenase (LDH) release and results expressed as % cytotoxicity. Tests were positive, with EOM cells, in 65% of patients with TAO, 75% with ocular myopathy, a variant of TAO in which periorbital inflammation is minimal, 50% with euthyroid Graves’ disease defined as ophthalmopathy associated with subclinical thyroiditis and in 50% of patients with stable lid lag and retraction but no other signs of progressive ophthalmopathy, but in only 13% of patients with Graves’ hyperthyroidism without ophthalmopathy, 10% with Hashimoto’s thyroiditis and 14% of patients with other thyroid disorders. Tests were positive, with Müller’s muscle cells, in 40% of patients with TAO, 25% with ocular myopathy, 40% with euthyroid Graves’ disease, 44% with lid lag, 19% with Graves’ hyperthyroidism, 50% with Hashimoto’s thyroiditis and in 37.5% of patients with other thyroid disorders. When skeletal muscle cells were used as target, tests were positive in 13% of patients with TAO, 31% with lid lag, 25% with Graves’ hyperthyroidism and in 29% of patients with Hashimoto’s thyroiditis, but in no patient with euthyroid Graves’ disease or other thyroid disorders. Tests were negative in all patients and normals tested when EOM-derived fibroblasts were used as targets in ADCC. A significant positive correlation between % cytotoxicity against EOM cells and the severity of the eye muscle dysfunction expressed as an eye muscle index, was observed in patients with TAO. There was a significant negative correlation between the duration of eye disease and % cytotoxicity against EOM cells, suggesting higher titers of cytotoxic antibodies in the early stages of TAO. There was no correlation between % cytotoxicity and serum level of anti-TSH receptor antibodies, measured in a radioreceptor assay. These findings suggest that autoimmunity against Müller’s muscle may play a role in the pathogenesis of persistent lid lag and retraction. The nature of the EOM and Müller’s muscle autoantigens recognized by cytotoxic antibodies in the serum of patients with TAO and related eye disorders is unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weetman A.P. Update: Thyroid-associated ophthalmopathy. Autoimmunity 12: 215, 1992.

    Article  CAS  PubMed  Google Scholar 

  2. Wall J.R., Boucher B.A., Salvi M., Zhang Z.G., Kennerdell J., Tyutyunikov A., Genovese C. Pathogenesis of thyroid associated ophthalmopathy: an autoimmune disorder of the EM associated with Graves’ hyperthyroidism and Hashimoto’s thyroiditis. J. Clin. Immunol. Immunopathol. 68: 1, 1993.

    Article  CAS  Google Scholar 

  3. Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 2: 25, (editorial), 1991.

    Article  Google Scholar 

  4. McLachlan S.M., Bahn R., Rapoport B. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodie. Autoimmunity 14: 143, 1992.

    Article  CAS  PubMed  Google Scholar 

  5. Bahn R.S., Dutton C.M., Heufelder A.E., Sarkar G. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves’ ophthalmopathy. Clin. Endocrinol. Metab. 78: 256, 1994.

    CAS  Google Scholar 

  6. Perros P., Kendall-Taylor P. Demonstration of thyrotropin binding sites in orbital connective tissue: possible role in the pathogenesis of thyroid-associated ophthalmopathy. J. Endocrinol. Invest. 17: 163, 1994.

    CAS  PubMed  Google Scholar 

  7. Salvi M., Miller A., Wall J.R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in serum of patients with thyroid-associated ophthalmopathy. FEBS Lett. 232: 135, 1988.

    Article  CAS  PubMed  Google Scholar 

  8. Hiromatsu Y., Sato M., Tanaka K., Shoji S., Nonaka K., Chinami M., Fukazawa H. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot. Autoimmunity 14: 1, 1993.

    Article  Google Scholar 

  9. Wang P.W., Hiromatsu Y., Laryea E., Wosu L., How J., Wall J.R. Immunologically mediated cytotoxicity against human eye muscle cells in Graves, ophthalmopathy. J. Clin. Endocrinol. Metab. 63: 316, 1986.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang Z.G., Medeiros-Neto G., Iacona A., Lima N., Hiromatsu Y., Salvi M., Triller H., Bernard N., Wall J.R. Studies of cytotoxic antibodies against eye muscle antigens in patients with thyroid-associated ophthalmopathy. Proc. Int. Symp. Graves’ Ophthalm., Helsinki, May 1989. Acta Endocrinol. (Copenh.) 21 (Suppl 2): 25, 1989.

    Google Scholar 

  11. Hiromatsu Y., Fukazawa H., How J., Wall J.R. Antibody-dependent cell-mediated cytotoxicity against human eye muscle and orbital fibroblasts in Graves’ ophthalmopathy-roles of Class II MHC antigen expression and γ-interferon action on effector and target cells. Clin. Exp. Immunol. 70: 597, 1987.

    Google Scholar 

  12. Hiromatsu Y., Fukazawa H., Guinard F., Salvi M., How J., Wall J.R. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 67: 565, 1988.

    Article  CAS  PubMed  Google Scholar 

  13. Medeiros-Neto G., Zhang Z.G., Lima L., Iacona A., Liberman A., Salvi M., Wall J.R. Immunologically mediated cytotoxicity against human eye muscle and thyroid cells in euthyroid and thyrotoxic Graves’ Ophthalmopathy. Autoimmunity 9: 293, 1991.

    Article  CAS  PubMed  Google Scholar 

  14. Hiromatsu Y., Cadarso L., Salvi M., Wall J. Significance of cytotoxic eye muscle antibodies patients with thyroid associated ophthalmopathy. Autoimmunity 5: 205, 1990.

    Article  CAS  PubMed  Google Scholar 

  15. Korzeniewski C., Callewaert D.M. An Enzyme-Release Assay for Natural Cytotoxicity. J. Immunol. Methods 64: 313, 1983.

    Article  CAS  PubMed  Google Scholar 

  16. Barsouk A., Wengrowitz S., Scalise D., Stolarski C., Nebes V., Sato M., Wall J.R. New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirms their importance in thyroid-associated ophthalmopathy. Thyroid 5: 195, 1995

    CAS  PubMed  Google Scholar 

  17. Burch H.B., Wartofsky L. Graves’ Ophthalmopathy: Current concepts Regarding Pathogenesis and Management. Endocrine Rev. 14: 747, 1993.

    CAS  Google Scholar 

  18. Solovyeva T.P. Endocrine ophthalmopathies. Problems of rational classification. Aeolus Press Amsterdam. Orbit 8: 193, 1989.

    Article  Google Scholar 

  19. Salvi M., Zhang Z.G., Haegert D., Woo M., Liberman A., Cadarso L., Wall J.R. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. Clin. Endocrinol. Metab. 70: 89, 1990.

    Article  CAS  Google Scholar 

  20. Witkowski J.A., Durbidge M., Dubowitz V. Growth of human muscle tissue culture. An Improved Technique. In Vitro 12: 98, 1976.

    Article  CAS  PubMed  Google Scholar 

  21. Gilbert S.F., Migeon B.R. D-valine as a selective agent for normal human and rodent epithelial cells in culture. Cell 5: 11, 1975.

    Article  CAS  PubMed  Google Scholar 

  22. Lazzaro V.A., Walker R.J., Duggin G.G., Phippard A., Howarth J.S., Tiller D.J. Inhibition of fibroblast proliferation in L-valine reduced selective media. Res. Comm. Chem. Pathol. Pharmacol. 75: 39, 1992.

    CAS  Google Scholar 

  23. Decker T., Lohmann-Matthes M.L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Meth. 15: 61, 1988.

    Article  Google Scholar 

  24. Fox J. Linear statistical models and related methods. J. Wiley & Sons, NY, 1984.

    Google Scholar 

  25. Salvi M., Scalise D., Stolarski C., Arthurs B., Lindley S., Kennerdell J., Wall J.R. Upper eyelid retraction in the absence of other evidence for progresive ophthalmopathy is associated with eye muscle autoantibodies. Clin. Immunol. Immunopathol. 74: 44, 1995.

    Article  CAS  PubMed  Google Scholar 

  26. Bahn R.S., Heufelder A.E. Orbital connective tissue in endocrine ophthalmopathy. In: Kahaly G. (Ed.): Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Dev. Ophthalmol. Basel, Karger 25: 46, 1993.

    CAS  Google Scholar 

  27. Rotella C.M., Zonefrati R., Toccafondi R., Valente W.A., Kohn L.D. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves’ sera. J. Clin. Endocrinol. Metab. 62: 357, 1986.

    Article  CAS  PubMed  Google Scholar 

  28. Kiljanski J., Wall J.R. Is the ocular muscle cell a target of the immune system in endocrine ophthalmopathy? Proc. Intl. Arch. Allergy Immunol. 106: 204, 1995.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Thyroid Eye Disease Research Laboratory, Allegheny-Singer Research Institute, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, Pennsylvania, 15212, USA

    A. Barsouk, J. Kiljanski, C. Stolarski, V. Nebes &  J. R. Wall

  2. Department of Ophthalmology, Allegheny General Hospital, Pittsburgh, Pennsylvania, Canada

    K. A. Peele & J. S. Kennerdell

  3. Department of Medicine, The Wellesley Hospital, Toronto, Ontario, Canada

    R. Volpe

Authors
  1. A. Barsouk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. A. Peele
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Kiljanski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Stolarski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Nebes
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. S. Kennerdell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Volpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. R. Wall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barsouk, A., Peele, K.A., Kiljanski, J. et al. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction. J Endocrinol Invest 19, 334–341 (1996). https://doi.org/10.1007/BF03344966

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344966

Keywords

Search

Navigation